Kum & Go is excited to partner with CB4 to identify sales opportunities, said Kum & Go VP of Operations, Marty Roush. We announced this tool to our District Supervisors and they can’t wait to put this in the hands of their teams to improve operational execution.
Read more here.
![[Alpha Tau in GlobeNewswire] Alpha Tau announces the acceptance in major peer-reviewed journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of two landmark pre-clinical studies demonstrating significant potential synergies between the Alpha DaRT treatment and standard-of-care immunotherapy, chemotherapy and anti-angiogenic therapy](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
